Pavilion Capital, a Singapore-based investment company, focuses on private equity and venture capital funds, as well as direct investments in companies driving growth and transformation across North Asia and Southeast Asia, particularly in innovative technology and healthcare sectors. Its strategy includes Asia-focused private equity fund of funds and co-investment strategies.
32% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $92.2M (across 32 rounds with reported amounts).
Portfolio
34
Fund Size
$9B
Top Stage
Series C
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
34 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Genspark | Series B | $275M | Nov 2025 |
 Daloopa | Series A | $13M | Jul 2025 |
 Netradyne | Series D | $90M | Jan 2025 |
| LLhoopa | Growth | $80M | Jul 2024 |
| Eetaily | Series A | $17.8M | Nov 2023 |
| AAccredify | Series A | $7M | Apr 2023 |
 Flare Therapeutics Inc. | Series B | $123M | Mar 2023 |
 VOW | Series A | $49.2M | Nov 2022 |
| IInsilico | Series D | $95M | Aug 2022 |
 Insilico Medicine | Series D | $95M | Aug 2022 |
| Insilico Medicine | Series C | $95M | Jul 2022 |
 MegaRobo Technologies Ltd. | Series C | $300M | Jun 2022 |
| Insilico Medicine | Series D | $60M | Jun 2022 |
 SwatchOn | Series A | $10M | Apr 2022 |
 ENSEM Therapeutics Inc. | Series A | $67M | Apr 2022 |
 Rokt | Series E | $325M | Dec 2021 |
 HotSpot Therapeutics, Inc. | Series C | $100M | Nov 2021 |
| DDoctor Anywhere | Series C | $65.7M | Aug 2021 |
| Insilico Medicine | Series C | $255M | Jun 2021 |
 KAHR | Unknown | $46.5M | Jun 2021 |
 Waresix | Series B | $100M | Sep 2020 |
| EEverest Medicines | Series C | $310M | Jun 2020 |
 KAHR Medical | Series A | $18M | Feb 2020 |
 Appier | Series D | $80M | Nov 2019 |
| FFore Coffee | Seed | $8.5M | Feb 2019 |
Page 1 of 2
Top Co-Investors
B Capital6 shared
Warburg Pincus5 shared
Bold Capital Partners5 shared
Prosperity7 Ventures3 shared
Square Peg Capital3 shared
Mirae Asset3 shared
GGV Capital3 shared
BHR Partners2 shared
SMDV2 shared
EV Growth2 shared
EDBI2 shared
CRV (Charles River Ventures)2 shared
OurCrowd2 shared
Blackbird2 shared
Grok Ventures2 shared
Insignia Ventures Partners2 shared
Deerfield2 shared
Baidu Venture2 shared
Sinovation2 shared
Pfizer Ventures1 shared
Last updated: 12 April 2026